ALFA Filings
Every announcement, straight from the exchange
Every Mangalam Worldwide other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
8 announcements
The company filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026, detailing promoter and public shareholdings.
Mangalam Worldwide Limited submitted net worth certificates for its personal guarantors as of March 31, 2026. These disclosures provide transparency regarding the financial backing of the company's guarantees.
Mangalam Worldwide Limited released an independent valuation report valuing its fixed assets at ₹25.24 Crore. The appraisal supports the company's proposed issuance of Non-Convertible Debentures.
Government of India unveiled a ₹5 commemorative stamp honoring Mangalam Worldwide's founder. This prestigious national recognition highlights the company's 84-year industrial legacy.
Mangalam Worldwide's board approved a 1:10 stock split to enhance liquidity. The company also reported ₹1,214.98 crore revenue and approved a BSE Main Board listing.
Mangalam Worldwide Limited informed the exchange that it does not qualify as a 'Large Corporate' for F.Y. 2025-26. The company does not meet the SEBI criteria regarding outstanding long-term borrowings and credit ratings. Consequently, the requirement for Annual Disclosure under the SEBI Large Corporate framework is not applicable.
Mangalam Worldwide Limited has updated its list of authorized personnel under Regulation 30(5) of SEBI LODR. The Chairman, Managing Directors, and CFO are authorized to determine materiality, while the Company Secretary is designated for making stock exchange disclosures. This is a routine regulatory compliance update.
Mangalam Worldwide Limited disclosed that SEBI passed a Settlement Order on March 30, 2026, involving two common Independent Directors. The matter, relating to alleged financial misstatements at Mangalam Global Enterprise Limited, was settled by the individuals without admitting or denying findings. There is no material financial or operational impact on the company.